Moving Multiparticulates from Pediatric Formulation To Patient-Centric Drug Product Design

Patient-centric dosage-form design involves identifying the comprehensive needs of the target population and using those needs to design drug products that provide the best overall benefit-to-risk profile for the targeted patient population over the intended duration of treatment. This presentation examines the use of patient-centric principles in the design of dosage forms for pediatric patients, covering technology selection and formulation considerations. The advantages of lipid multiparticulates (LMPs) are reviewed. To learn more, please view our presentation.